Health Care & Life Sciences » Pharmaceuticals | Sequent Scientific Ltd.

Sequent Scientific Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,099,140.00
83,710.00
137,660.00
168,000.00
-
Depreciation, Depletion & Amortization
325,970.00
329,350.00
457,220.00
622,950.00
-
Other Funds
595,830.00
412,160.00
33,460.00
177,160.00
-
Funds from Operations
177,340.00
166,520.00
353,020.00
632,110.00
528,138.00
Changes in Working Capital
774,100.00
506,130.00
714,620.00
1,043,720.00
-
Net Operating Cash Flow
951,440.00
672,650.00
361,600.00
411,610.00
-
Capital Expenditures
857,330.00
909,340.00
655,380.00
988,970.00
-
Sale of Fixed Assets & Businesses
44,270.00
1,139,590.00
23,380.00
465,800.00
-
Purchase/Sale of Investments
5,120.00
561,180.00
1,192,190.00
74,160.00
-
Net Investing Cash Flow
807,940.00
1,636,170.00
3,201,460.00
1,190,010.00
-
Issuance/Reduction of Debt, Net
1,152,690.00
558,870.00
1,990,870.00
1,436,890.00
-
Net Financing Cash Flow
1,867,790.00
2,354,230.00
3,491,200.00
1,842,320.00
-
Net Change in Cash
94,370.00
22,440.00
18,220.00
240,700.00
-
Free Cash Flow
1,808,770.00
1,581,990.00
1,016,980.00
1,400,580.00
-
Net Assets from Acquisitions
-
1,305,240.00
1,377,270.00
751,680.00
-
Other Sources
-
-
-
10,680.00
-
Change in Capital Stock
715,100.00
1,795,360.00
5,482,070.00
405,430.00
-
Exchange Rate Effect
14,040.00
22,970.00
53,640.00
-
-

About Sequent Scientific

View Profile
Address
301/A, Dosti Pinnacle
Mumbai Maharashtra 400604
India
Employees -
Website http://www.sequent.in
Updated 09/14/2018
SeQuent Scientific Ltd. engages in the manufacture of active pharmaceutical ingredients for the animal health sector. It offers nonsteroidal anti-inflammatory drugs, antibiotics, anthelmintics, vitamins, prostaglandins, and hormonal. It operates through the following geographical segments: Europe, Asia, and Rest of World.